Lumos Pharma, Inc. (LUMO)

Lumos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	23.18	35.08	56.01	94.81	98.68	4.95
Short-Term Investments	0	1	11.35	0	0	0
Cash & Cash Equivalents	23.18	36.08	67.36	94.81	98.68	4.95
Cash Growth	-60.02%	-46.44%	-28.95%	-3.92%	1892.71%	-95.90%
Receivables	0.18	0.21	0.22	0.13	26.15	0.04
Other Current Assets	4.18	3.75	4.43	4.74	3.62	0.08
Total Current Assets	27.54	40.04	72.01	99.68	128.45	5.07
Property, Plant & Equipment	0.53	0.6	0.28	0.64	0.58	0.46
Total Long-Term Assets	0.53	0.6	0.28	0.64	0.58	0.46
Total Assets	28.08	40.64	72.29	100.31	129.03	5.53
Accounts Payable	0.57	0.89	0.28	0.61	0.24	0.37
Current Debt	0.29	0.28	0.23	0.35	0.32	0.19
Other Current Liabilities	3.55	5.86	6.2	4.17	5.9	0.71
Total Current Liabilities	4.41	7.03	6.71	5.13	6.46	1.26
Long-Term Debt	0.23	0.3	0	0.21	0	0.19
Other Long-Term Liabilities	6	6	6	6	6	0
Total Long-Term Liabilities	6.23	6.3	6	6.21	6	0.19
Total Liabilities	10.64	13.33	12.71	11.34	12.46	1.45
Total Debt	0.52	0.59	0.23	0.56	0.32	0.38
Debt Growth	23.04%	151.07%	-58.17%	74.61%	-16.05%	265.38%
Retained Earnings	-171.96	-161.52	-127.48	-96.42	-65.99	-59.68
Comprehensive Income	0	0	-0.01	0	0	0
Shareholders' Equity	17.44	27.31	59.58	88.98	116.57	-59.46
Net Cash / Debt	22.66	35.49	67.13	94.25	98.36	4.57
Net Cash / Debt Growth	-60.63%	-47.13%	-28.78%	-4.18%	2051.36%	-96.21%
Net Cash Per Share	2.80	4.36	8.02	11.31	14.51	3.51
Working Capital	23.13	33.01	65.3	94.55	121.99	3.81
Book Value Per Share	2.15	3.35	7.12	10.68	17.20	-45.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).